Cancer Letters

Cancer Letters

Volume 338, Issue 1, 10 September 2013, Pages 89-93
Cancer Letters

Mini-review
Lung cancer stem cells: Progress and prospects

https://doi.org/10.1016/j.canlet.2012.08.014Get rights and content

Abstract

Epithelial stem cells are critical for tissue generation during development and for repair following injury. In both gestational and postnatal stages, the highly branched and compartmentalized organization of the lung is maintained by multiple, resident stem/progenitor cell populations that are responsible for the homeostatic maintenance and injury repair of pulmonary epithelium. Though lung epithelial injury in the absence of oncogenic mutation is more commonly expressed as chronic lung disease, lung cancer is the most common form of death worldwide and poses a highly significant risk to human health. Cancer is defined by the cell of origin, responsible for initiating the disease. The Cancer Stem Cell Hypothesis proposes that cancer stem cells, identified by stem-like properties of self-renewal and generation of differentiated progeny, are responsible for propagating growth and spread of the disease. In lung cancer, it is hypothesized that cancer stem cells derive from several possible cell sources. The stem cell-like resistance to injury and proliferative potentials of bronchioalveolar stem cells (BASCs) and alveolar epithelial type II cells (AEC2), as well as cells that express the cancer stem cell marker glycoprotein prominin-1 (CD133) or markers for side populations make them potential reservoirs of lung cancer stem cells. The abnormal activation of pathways that normally regulate embryonic lung development, as well as adult tissue maintenance and injury repair, including the Wnt, Hedgehog (Hh) and Notch pathways, has also been identified in lung tumor cells. It is postulated that therapies for lung cancer that specifically target stem cell signaling pathways utilized by lung cancer stem cells could be beneficial in combating this disease.

Highlights

Lung stem cells are critical for tissue generation/regeneration during development and repair. ► Multiple sources for lung cancer stem cells reflect the compartmentalized nature of the lung. ► Potential reservoirs of lung cancer stem cells include BASC, AEC2, side and CD133+ populations. ► Abnormal activation of embryonic Wnt, Hh and Notch pathways occurs in lung tumor stem cells.

Introduction

Stem cells, which are critical for the generation and regeneration of all tissues, are defined by their undifferentiated phenotype. Stem cells divide both symmetrically and asymmetrically, with the mode of propagation dependent on cell type, differentiation status, niche context and requirements of the tissue dependent on the stem cell pool in question. Symmetrical division, as occurs in the intestinal crypts, produces identical daughter cells that supply the pool needed to generate the rapidly turned over tissue of the gut epithelium [1], [2], [3]. In the distal embryonic lung, the distribution of molecules that specify polarity, including the Notch-binding protein Numb, appears to drive the stem cell decision to divide symmetrically or asymmetrically [4]. Asymmetric division is the method by which stem cells generate both undifferentiated and differentiated offspring during development and in multiple, differentiated tissues. The stem cell ability to self-renew in order to produce an adequate supply of cells that are identical to the cell of origin and to each other allows them to be conserved for future use in tissue repair [2], [5], [6]. The stem cell ability to differentiate into specialized cells when exposed to certain experimental and physiological conditions defines their role in tissue regeneration [5], [6], [7].

In adult organisms, tissue specific stem cells are found throughout the body. The ability to differentiate into a variety of cell types as needed allows the replenishment of damaged or aged cells that is required to withstand normal wear and tear [5], [6], [7], [8]. Each stem cell division involves a decision to self-renew or differentiate. The transcription factors Oct4, Sox2 and Nanog regulate factors that inhibit differentiation and promote self-renewal [5]. Stem cell self-renewal and differentiation are regulated by multiple protein signaling pathways. Pathways of note include the WNT, Hedgehog (Hh), and Notch signaling cascades [8], [9]. These signaling pathways are essential in development during embryogenesis and in the regulation of stem-cell function in adult organs. Stem cells play a critical role in the homeostatic maintenance of functional epithelium. Within adult organs, stem cell activity is specific to discrete compartments of functioning organs. This is particularly true in the highly branched and specialized structures that make up the lung.

Section snippets

Lung development: role of lung stem cells in function and homeostasis

The embryonic lung develops from a small stem cell population originating from the laryngotracheal groove, leading to the morphogenesis of the intricate branched structure of the bronchial and alveolar epithelium [10]. Following birth, the lung alveolar epithelium plays a vital role in gas exchange. Lung function is supported by the combined efforts of the highly vascularized, extraordinarily large surface area within alveoli that facilitate gas exchange via alveolar epithelial type 1 cells

Lung cancer: environmental and genetic influences

Despite the slow rate of distal lung epithelial cell turnover and the propensity for human lung tissue to scar rather than regenerate, lung cancers are prevalent, most probably due to the self-inflicted insults of smoking and passive insults due to atmospheric toxins and carcinogens. The correlation between inflammation and carcinogenesis has been substantiated by a number of studies. Cigarette smoking is known to produce an inflammatory response within the lung. The carcinogens found in

Cancer and cancer stem cells

Cancer is described as a disease of unregulated proliferation of abnormal cells eventually leading to the invasion of surrounding tissues. Cancer is identified by its origin, or the type of cell that first suffered oncogenic mutation. As the disease progresses, uncontrolled cellular growth produces lesions comprised of abnormal tissues called tumors. Tumors are comprised of a heterogeneous population of cells [27], [28]. Among this varied cell population are tumor forming cells, which possess

Evidence for lung cancer stem cells

Because of the highly compartmentalized nature of the lung, multiple epithelial cell types, from the trachea to the distal airways, have been designated putative lung progenitors due to their stem/progenitor cell-like responses to injury. Studies that have delved into the behaviors and characteristics of these populations have identified limited, local progenitors that can repopulate injured tissue following experimental injury [12], [35], [36], [37]. In addition, AEC2 have been characterized

Lung cancer stem cells as a reservoir for disease and metastasis

In addition to being highly responsive to proliferative stimuli, BASCs and a subset of AEC2 are also resistant to damage and injury and continue to proliferate within the epithelium during repair following lung damage [39], [45], [46], [47], [48], [49], [50], [51], [52]. This is an additional, critical characteristic for both normal tissue and cancer stem cells. In the case of lung cancer, cells that are resistant to injury could serve as a stem cell-like reservoir for generating additional

Lung cancer stem cells as therapeutic targets

Identifying CSCs within lung tumors provides a focus for a wide range of possible treatments and therapies that specifically target stem-like cells. Several possible therapeutic targets unique to these cells include the repair or correction of dysfunctional signaling cascades, including altered Wnt, Hedgehog, and Notch pathways [53]. These signaling pathways play vital roles in lung development and in the regulation of stem cell self-renewal and may play a role in the initiation of

Conclusions

Ongoing analysis of the initiation and propagation of tumors by cancer stem cells, which are hypothesized to derive from resident, local epithelial progenitor cell populations, has provided new insight into the progression of this disease. The stem cell-like resistance to injury and proliferative potentials of cancer initiating cells appears to contribute to cancer growth and resistance to treatment. Under normal conditions the lung exhibits a low rate of cellular turnover, but exposure to

Acknowledgements

This work was partially supported by NIH Grant R01 HL 065352 to B.D. and a CIRM Bridges to Stem Cell Research Intern stipend to A.L. from Award RFA0804 to Pasadena City College.

References (77)

  • S.D. Girouard et al.

    Melanoma stem cells: not rare, but well done

    Lab. Invest.

    (2011)
  • M.F. Clarke et al.

    Stem cells and cancer: two faces of Eve

    Cell

    (2006)
  • K.U. Hong et al.

    Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium

    Am. J. Pathol.

    (2004)
  • X. Liu et al.

    Stem cells in the lung

    Methods Enzymol.

    (2006)
  • A. Berns

    Stem cells for lung cancer?

    Cell

    (2005)
  • J.R. Kratz et al.

    Cancer stem cells in lung tumorigenesis

    Ann. Thorac. Surg.

    (2010)
  • E.L. Rawlins et al.

    The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium

    Cell Stem Cell

    (2009)
  • M.R. Alison

    Stem cells and cancer in the aerodigestive tract

    Eur. J. Cancer

    (2009)
  • J.P. Sullivan et al.

    Tumor oncogenotypes and lung cancer stem cell identity

    Cell Stem Cell

    (2010)
  • X.W. Ding et al.

    ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy

    Life Sci.

    (2010)
  • T.C. Camilli et al.

    Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression

    Biochem. Pharmacol.

    (2010)
  • I. Gehrke et al.

    Targeting the Wnt/β-catenin/TCF/Lef1 axis in solid and haematological cancers: multiplicity of therapeutic options

    Eur. J. Cancer

    (2009)
  • B. He et al.

    Wnt signaling in stem cells and non-small-cell lung cancer

    Clin. Lung Cancer.

    (2005)
  • J. Mazieres et al.

    Wnt signaling in lung cancer

    Cancer Lett.

    (2005)
  • S. Chi et al.

    Activation of the hedgehog pathway in a subset of lung cancers

    Cancer Lett.

    (2006)
  • D. Dingli et al.

    (A)symmetric stem cell replication and cancer

    PLoS Comput. Biol.

    (2007)
  • S.J. Morrison et al.

    Asymmetric and symmetric stem-cell divisions in development and cancer

    Nature

    (2006)
  • A.H. El-Hashash et al.

    Cell polarity and spindle orientation in the distal epithelium of embryonic lung

    Dev. Dyn.

    (2011)
  • S. He et al.

    Mechanisms of stem cell self-renewal

    Annu. Rev. Cell Dev. Biol.

    (2009)
  • T. Reya et al.

    Stem cells, cancer, and cancer stem cells

    Nature

    (2001)
  • R.A. Nimmo et al.

    An elegant miRror: microRNAs in stem cells, developmental timing and cancer

    Chromosoma

    (2009)
  • R. Pardal et al.

    Applying the principles of stem-cell biology to cancer

    Nat. Rev.

    (2003)
  • C.D. Peacock et al.

    Cancer stem cells and the ontogeny of lung cancer

    J. Clin. Oncol.

    (2008)
  • A. Yagui-Beltran et al.

    The role of cancer stem cells in neoplasia of the lung: past, present and future

    Clin. Transl. Oncol.

    (2008)
  • A.C. MacKinnon et al.

    The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies

    Br. Med. Bull.

    (2010)
  • J.C. Snyder et al.

    Endogenous lung stem cells and contribution to disease

    J. Pathol.

    (2009)
  • J.P. Sullivan et al.

    Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy

    Cancer Metast. Rev.

    (2010)
  • J. Dong et al.

    Lung cancer developmental networks gone awry?

    Cancer Biol. Ther.

    (2009)
  • Cited by (79)

    • HDAC11: a rising star in epigenetics

      2020, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      High levels of HDAC11 are observed in both lung adenocarcinoma and squamous cell carcinoma and are associated with poor prognosis. Cancer stem cells (CSCs) are implicated in tumor initiation, metastasis, dormancy and recurrence [32]. Interestingly, HDAC11 interacts with the transcription factor Gli to promote the expression of the embryonic stem cell transcription factor Sox2,which contributes to the genesis and maintenance of CSCs [33,34].

    View all citing articles on Scopus
    View full text